Compounds > meglumine

meglumine and pentoxifylline

meglumine has been researched along with pentoxifylline in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Báfica, A; Barral, A; Freitas, LA; Nascimento, EG; Oliveira, F1
Nilforoushzadeh, MA; Sadeghian, G1
de Moura, FJ; de Souza Furtado, R; Leal, PP; Muniz-Junqueira, MI; Veiga, JP1

Trials

1 trial(s) available for meglumine and pentoxifylline

ArticleYear
Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis.
    International journal of dermatology, 2006, Volume: 45, Issue:7

    Topics: Adolescent; Adult; Antiprotozoal Agents; Double-Blind Method; Drug Therapy, Combination; Female; Hematologic Agents; Humans; Iran; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentoxifylline; Treatment Outcome

2006

Other Studies

3 other study(ies) available for meglumine and pentoxifylline

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
American cutaneous leishmaniasis unresponsive to antimonial drugs: successful treatment using combination of N-methilglucamine antimoniate plus pentoxifylline.
    International journal of dermatology, 2003, Volume: 42, Issue:3

    Topics: Administration, Oral; Antiprotozoal Agents; Drug Therapy, Combination; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentoxifylline; Tumor Necrosis Factor-alpha

2003
Pentoxifylline prevents the meglumine antimonate-induced renal toxicity in rats, but not that induced by the inorganic antimony pentachloride.
    Toxicology, 2008, Jan-14, Volume: 243, Issue:1-2

    Topics: Animals; Antimony; Antiprotozoal Agents; Chlorides; Dose-Response Relationship, Drug; Kidney Diseases; Kidney Function Tests; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha

2008